Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cochrane on Diabetes Distress Interventions

Cochrane; 2017 Sep 27; Chew, Vos, et al

Psychological interventions do not appear to work better than usual care in relieving diabetes-related distress, according to a Cochrane review of 30 randomized controlled trials involving nearly 9,200 individuals. However, the interventions did provide some benefit for self-efficacy and small improvement in HbA1c levels. Interventions in the trials ranged between 1 and 12 months and mostly occurred in community settings. Among the findings (all based on low-quality evidence):

  • Psychological interventions had a small positive effect on confidence for self-care and HbA1c levels.
  • They had no firm effect on diabetes-related distress, health-related quality of life, death from any cause, adverse events, or blood pressure levels.
  • There was no evaluation of diabetes-related complications or socioeconomic effects.

Citation:

Chew B, Vos R, Metzendorf M, Scholten R, Rutten G. Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus. Cochrane Database of Syst Rev. 2017, Issue 9. Art. No.: CD011469. doi:10.1002/14651858.CD011469.pub2.

This Week's Must Reads

Cochrane on Clinician-Focused Weight Loss Tactics, Cochrane; 2017 Nov 30; Flodgren, et al

Cochrane on Delaying Diabetes in People with IGT, Cochrane; 2017 Dec 5; Hemmingsen, et al

Consider Using This Risk Tool to Predict T2D Risk, Diabetes Care; ePub 2017 Dec 1; Bergmark, Bhatt, et al

Dysglycemia Cause in Overweight Adults, Teens, Diabetes Care; ePub 2017 Nov 28; Chen, et al

FDA Approves Semaglutide for Type 2 Diabetes, Novo Nordisk news release; 2017 Dec 5

Must Reads in Diabetes

Cochrane on Delaying Diabetes in People with IGT, Cochrane; 2017 Dec 5; Hemmingsen, et al

Consider Using This Risk Tool to Predict T2D Risk, Diabetes Care; ePub 2017 Dec 1; Bergmark, Bhatt, et al

Dysglycemia Cause in Overweight Adults, Teens, Diabetes Care; ePub 2017 Nov 28; Chen, et al

FDA Approves Semaglutide for Type 2 Diabetes, Novo Nordisk news release; 2017 Dec 5

Hospitalization in Those With, Without Diabetes, Diabetes Care; ePub 2017 Nov 17; Burrows, et al